Catalyst Wire Dossier Catalyst Wire Dossier

Telmisartan plus hydrochlorothiazide

telmisartan/hydrochlorothiazide · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Telmisartan plus hydrochlorothiazide, covering 2014-07-08 to 2014-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension [Phase 3]

See pricing